11
Oct 2022
20:26 E.S.T.

TALEN®-mediated engineering of HSPC enables systemic delivery of IDUA – ESGCT 2022- Abstract

Download the PDF file
11
Oct 2022
18:33 E.S.T.

TALEN®-mediated engineering of HSPC enables systemic delivery of IDUA- ESGCT 2022- Poster Presentation

Download the PDF file
10
Jun 2022
17:39 E.S.T.

Pre-Clinical Proof Of Concept Demonstrates Robust Activity Of UCART20x22 Dual CAR T-Cells For The Treatment Of B-Cell Malignancies – EHA 2022- Poster Presentation

Download the PDF file
10
Jun 2022
17:35 E.S.T.

Preliminary Results from the Flu/Cy/Alemtuzumab arm of the Phase I BALLI-01 Trial of UCART22- EHA 2022- Poster Presentation

Download the PDF file
16
May 2022
18:22 E.S.T.

Endowing Universal CAR T-cell with Immune-Evasive Properties Using TALEN® -Gene Editing- ASGCT 2022- Oral Presentation

Download the PDF file
11
Apr 2022
15:16 E.S.T.

UCART20x22: First allogeneic dual CAR T-cell therapy for the treatment of B-cell malignancies – AACR 2022 – Abstract

Download the PDF file
10
Apr 2022
20:41 E.S.T.

UCART20x22: First allogeneic dual CAR T-cell therapy for the treatment of B-cell malignancies – AACR 2022 – Poster Presentation

Download the PDF file
11
Dec 2021
15:57 E.S.T.

Pre-clinical Development of a Highly Efficient TALEN®- ASH 2021- Poster Presentation

Download the PDF file
11
Dec 2021
15:55 E.S.T.

Preliminary Results from the Flu/Cy/Alemtuzumab arm of the Phase I BALLI-01 Trial of UCART22- ASH 2021- Poster Presentation

Download the PDF file